Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Aerobic exercise may help Parkinson's victims

June 28, 2010 3:35 pm | by Arizona State University | News | Comments

ASU researchers are testing ideas for exercise regimens that promise to help people lessen some symptoms of Parkinson's disease.read more

TOPICS:

Halozyme says enzyme boosts insulin absorption

June 28, 2010 2:45 pm | by The Associated Press | News | Comments

Halozyme Therapeutics Inc. said Monday a study showed that that addition of rHuPH20 recombinant human hyaluronidase to three different mealtime insulin analogs accelerated their absorption.The acceleration of the insulin boosted its effectiveness during the first hour after injection.The study...

FDA OKs American Medical's incontinence treatment

June 28, 2010 1:45 pm | by The Associated Press | News | Comments

Medical device maker American Medical Systems Holdings Inc. said Monday the Food and Drug Administration has cleared the company to market its treatment for female stress urinary incontinence.The company said over 33 million women worldwide are affected by SUI, a condition in which activities...

Advertisement

New products drive strong 2Q sales for 3M

June 28, 2010 12:45 pm | by The Associated Press | News | Comments

Scotch tape and Post-it Note maker 3M Co. says that new products and strong demand in emerging economies will push its second-quarter sales above Wall Street expectations.The company says it expects sales to range between $6.6 billion and $6.75 billion for the three-month period ending in June....

Humedica poised for success in health data sector

June 28, 2010 10:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Data that help doctors and life sciences companies improve patient care and reduce costs will be their most valuable asset in five years, according to a survey by PricewaterhouseCoopers. If so, then Boston-based Humedica, Inc. stands to be a big winner.

Recondo Technology Announces Integration Initiative for US Hospital Systems

June 28, 2010 10:37 am | by Bio-Medicine.Org | News | Comments

GREENWOOD VILLAGE, Colo. , June 28 /- Recondo Technology, a leading provider of revenue cycle solutions for the healthcare industry, announced today the general availability of a suite of tools and services to integrate various and disparate hospital systems, applications, software...

TOPICS:

Mr. Jean-Pierre Garnier Concludes his Mission at the Pierre Fabre Company

June 28, 2010 10:36 am | by Bio-Medicine.Org | News | Comments

CASTRES, France , June 28, 2010 /- Mr Jean-Pierre Garnier will step down on September 1st 2010, two years after having been appointed CEO of the Pierre Fabre Group. "The Company is in excellent health, and is poised to experience a bright future ; I am glad to have contributed to its...

TOPICS:

Study Shows Gradual Addition of NovoLog® at Mealtime Can Reduce A1c in Type 2 Diabetes Patients

June 28, 2010 10:36 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla. , June 28 /- Today Novo Nordisk announced results of its STEPwise™ trial, which identified a method of intensifying insulin treatment with NovoLog® (insulin aspart [rDNA origin] injection). The study, presented at the American Diabetes Association (ADA) 2010...

TOPICS:
Advertisement

Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at MIT

June 28, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

RARITAN, N.J. , June 28 /- Ortho-McNeil-Janssen Pharmaceuticals, Inc. today announced the signing of a five-year collaboration agreement with the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology .  Called TRANSCEND, the...

TOPICS:

Abbott Receives FDA Clearance for Molecular Diagnostic Test for Detection of Chlamydia and Gonorrhea Infections

June 28, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

DES PLAINES, Ill. , June 28 /- Abbott (NYSE: ABT ) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation's most prevalent sexually...

TOPICS:

Global Acute Coronary Syndrome Industry

June 28, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK , June 28 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Acute Coronary Syndrome industry http://www.reportlinker.com/p0197235/Global-Acute-Coronary-Syndrome-industry.html This report analyzes the globa...

TOPICS:

Studies of women's attitudes to 'social egg freezing' find reasons differ with age

June 28, 2010 8:34 am | by EurekAlert | News | Comments

(European Society of Human Reproduction and Embryology) Women of different ages differ in their reasons for wishing to undergo egg freezing, show two studies presented to the 26th annual meeting of the European Society of Human Reproduction and Embryology today.

TOPICS:

Endometriosis has a significant effect on women's work productivity, first

June 28, 2010 8:34 am | by EurekAlert | News | Comments

(European Society of Human Reproduction and Embryology) The first worldwide study of the societal impact of endometriosis has found a significant loss of work productivity among those women who suffer from the condition.

TOPICS:

Overweight women undertaking ART twice as likely to miscarry as their slimmer counterparts

June 28, 2010 8:34 am | by EurekAlert | News | Comments

(European Society of Human Reproduction and Embryology) Being overweight leads to a greater risk of miscarriage for patients undergoing assisted reproductive technology, the 26th annual conference of the European Society of Human Reproduction and Embryology heard today. Dr. Vivian...

TOPICS:

Screening for transmissible disease in ART patients not necessary at each donation

June 28, 2010 8:34 am | by EurekAlert | News | Comments

(European Society of Human Reproduction and Embryology) European legislation that requires all couples undergoing assisted reproduction treatment to be screened for HIV and hepatitis at the time of every sperm or egg donation is unnecessary, expensive, and potentially distressing...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading